scispace - formally typeset
M

Maria Laura Avantaggiati

Researcher at Georgetown University Medical Center

Publications -  65
Citations -  10731

Maria Laura Avantaggiati is an academic researcher from Georgetown University Medical Center. The author has contributed to research in topics: Transcription factor & Transactivation. The author has an hindex of 36, co-authored 64 publications receiving 9876 citations. Previous affiliations of Maria Laura Avantaggiati include Policlinico Umberto I & Sapienza University of Rome.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Recruitment of p300/CBP in p53-Dependent Signal Pathways

Maria Laura Avantaggiati, +5 more
- 27 Jun 1997 - 
TL;DR: It is shown that p53, in both wild-type and mutant conformation, forms a specific protein complex with p300, and p300 inhibits a promoter containing the DNA-binding sequences for the transcription factor AP1, in a p300-dependent manner.
Journal ArticleDOI

p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation.

Maofu Fu, +8 more
- 07 Jul 2000 - 
TL;DR: It is demonstrated that the androgen receptor can be modified by acetylation in vitro and in vivo, and the identification of the AR as a direct target of histone acetyltransferase co-activators has important implications for targeting inhibitors of AR function.
Journal ArticleDOI

p300 and CBP: partners for life and death.

Antonio Giordano, +1 more
- 01 Nov 1999 - 
TL;DR: This review will focus on mechanistic and theoretical questions pertaining to the mode of action of p300 and CBP posed by works performed in animal and in vitro model systems.
Journal ArticleDOI

p300 is required for MyoD‐dependent cell cycle arrest and muscle‐specific gene transcription

Pier Lorenzo Puri, +7 more
- 15 Jan 1997 - 
TL;DR: It is demonstrated that, in differentiating skeletal muscle cells, p300 physically interacts with the myogenic basic helix–loop–helix (bHLH) regulatory protein MyoD at its DNA binding sites, and p300 potentiates MyOD‐ and myogenin‐dependent activation of transcription from E‐box‐containing reporter genes.